Home Contact Us Site Map



Corporate Finance
Strategic Advisory
Investor Services
Track Record

 

LifeTech Capital, a division of Aurora Capital, has engaged in the following recent investment banking transactions since 2011. Click here for LifeTech Capital transactions dated earlier than 2011.

Table Pier Pharmaceuticals, Inc.
    August 2012		 Acquisition by Cortex Pharmaceuticals, Inc.
Table Financial Advisor

Table TBT Group Inc.
    2011
    2012

 Private Placement
Table Exclusive Placement Agent

Table Stem Cells, Inc.
    December 2011		 Public Offering
Table Exclusive Financial Advisor

<
Table Peregrine Pharmaceuticals, Inc.
    September 2011		 Registered Direct Offering
Table Financial Advisor

Table NovaBay Pharmaceuticals, Inc.
    July 2011		 Registered Direct Offering
Table Financial Advisor

Table Discovery Technology International, Inc.
    May 2011		 Series B Preferred Stock Offering
Table Exclusive Placement Agent

Table BioNovo, Inc.
    February 2011		 Follow-on Stock Offering
Table Exclusive Financial Advisor

Table Echo Therapeutics, Inc.
    January 2011		 Private Placement
Table Placement Agent

 

Aurora Capital LLC has completed offerings for life sciences companies for over a decade; deals have included:

Table Cortex Pharmaceuticals Inc.
    March 2013		 Board Election and Management
Re-Structuring
Table Aurora Capital LLC Affiliates Elected to a Majority of the Board of Directors

Aurora IntelliCell Biosciences, Inc.
    December 2012		 Private Placement
Aurora Exclusive Placement Agent

Table RegeneRx Biopharmaceuticals, Inc.
   March - August 2012		 Financial Advisory
Table Co-Exclusive Financial Advisor

Xintria Pharmaceutical, Inc. Private Placement
Sole Placement Agent

DOV Pharmaceutical, Inc. PIPE
Sole Placement Agent

DOV Pharmaceutical, Inc. Series D Convertible Preferred
Acted as a Selected Dealer on the Transaction with a Bulge Bracket Firm

DOV Pharmaceutical, Inc. Series C Convertible Preferred
Sole Placement Agent

DOV Pharmaceutical, Inc. and Elan Corporation Series B Equity and Debt Financing and Joint Venture
Sole Placement Agent

Neurocrine Biosciences and DOV Pharmaceutical, Inc. Sub-License, Equity Financing Series A Convertible Preferred
Advisor to DOV

InKine Private Equity Placement exempt from registration
Lead Co-Placement Agent

Encysive Pharmaceuticals (formerly, Texas Biotechnology Corp.) Private Equity Placement exempt from registration
Co-Exclusive Placement Agent

RegenRx Private Equity Placement exempt from registration
Sole Placement Agent in Company Offering

Boston Life Sciences Private Equity Placement exempt from registration
Assisted Another Investment Bank in a private placement

Cambridge Heart Private Equity Placement exempt from registration
Acted as Selected Dealer

Structural Bioinformatics Private Placement exempt from registration
(Series A and B)
Exclusive Placement Agent

ChromaXome Corp Private Placement exempt from registration
Exclusive Placement Agent

Vector Therapeutics Private Equity Placements exempt from registration (Series A and B)
Exclusive Placement Agent

Predict Inc. Private Equity Placement exempt from registration
Sole Placement Agent
Copyright © Aurora Capital, LLC | All Rights Reserved | Privacy Statement
Powered by